3 drug(s) with this reaction
1,253 total reports
Incorrect Product Administration Duration has been reported as an adverse reaction across 3 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,253 adverse event reports mention incorrect product administration duration in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with incorrect product administration duration, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have incorrect product administration duration listed in their FDA adverse event reports, sorted by report count:
In addition to incorrect product administration duration, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
3 drug(s) manufactured by Haleon Us Holdings Llc have incorrect product administration duration listed in their FDA adverse event reports: DOCOSANOL, GLYCERIN, LIDOCAINE, DEXTROMETHORPHAN POLISTIREX.
There are a combined 1,253 reports of incorrect product administration duration across 3 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.